The New England Journal of Medicine publishes phase III data that allows single-dose Xofluza to significantly reduce influenza virus transmission

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.